首页 | 本学科首页   官方微博 | 高级检索  
检索        


Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment
Authors:Yuji Okuno  Wataru Iwamoto  Noboru Matsumura  Sota Oguro  Taku Yasumoto  Takao Kaneko  Hiroyasu Ikegami
Institution:1. Musculoskeletal Intervention Center and Department of Sports Medicine, Edogawa Hospital, 2-24-18 Higashikoiwa, Edogawa-ku, Tokyo 133-0052, Japan;2. Departments of Orthopedic Surgery and Radiology, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan;3. Department of Interventional Radiology, Miyakojima IGRT Clinic, Miyakojima-ku, Osaka, Japan;4. Department of Orthopedic Surgery, Toho University School of Medicine (Ohashi), Meguro-ku, Tokyo, Japan
Abstract:

Purpose

To evaluate clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis resistant to conservative treatments.

Materials and Methods

This study comprised 25 patients (18 women and 7 men; mean age, 53.8 y; range, 39–68 y) with adhesive capsulitis resistant to conservative treatments. TAE was performed, and adverse events (AEs), pain visual analog scale (VAS) score changes, range of motion (ROM), and American Shoulder and Elbow Surgeons (ASES) scores were assessed.

Results

Abnormal vessels were identified in all patients. No major AEs were associated with TAE. One patient was lost to follow-up. The remaining 24 patients were available for final follow-up (mean, 36.1 months; range, 30–44 months). Of the 24 patients, 16 (67%) experienced quick improvement of nighttime pain (ie, VAS scores decreased > 50% from baseline) within 1 week, and 21 (87%) improved within 1 month. In terms of mean overall pain (ie, pain at its worst), VAS scores significantly decreased at 1, 3, and 6 months after treatment (82 mm before treatment vs 52, 19, and 8 mm after treatment; P < .001). ASES scores significantly improved at 1, 3, and 6 months after treatment (16.1 before treatment vs 41.4, 69.1, and 83.5 after treatment; P < .001). No symptom recurrence or late-onset AEs were observed. Shoulder ROM and function further improved during midterm follow-up.

Conclusions

TAE is a possible treatment option for patients with adhesive capsulitis that has failed to improve with conservative treatments.
Keywords:AE  adverse event  ASES  American Shoulder and Elbow Surgeons  IPM/CS  imipenem/cilastatin sodium  ROM  range of motion  TAE  transcatheter arterial embolization  VAS  visual analog scale
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号